IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Vaccine: X

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on September 3, 2024

Impact Score

2023-2024

2.80

h-Index

2023-2024

 18

Rank

2023-2024

 7726

SJR

2023-2024

 0.682

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Vaccine: X
Abbreviation Vaccine: X
Publication Type Journal
Subject Area, Categories, Scope Veterinary (miscellaneous) (Q1); Immunology and Microbiology (miscellaneous) (Q2); Infectious Diseases (Q2); Public Health, Environmental and Occupational Health (Q2); Molecular Medicine (Q3)
h-index 18
Overall Rank/Ranking 7726
SCImago Journal Rank (SJR) 0.682
Impact Score 2.80
Publisher Elsevier Ltd
Country United Kingdom
ISSN 25901362
Best Quartile Q1
Coverage History 2019-2023




About Vaccine: X


Vaccine: X is a journal covering the technologies/fields/categories related to Veterinary (miscellaneous) (Q1); Immunology and Microbiology (miscellaneous) (Q2); Infectious Diseases (Q2); Public Health, Environmental and Occupational Health (Q2); Molecular Medicine (Q3). It is published by Elsevier Ltd. The overall rank of Vaccine: X is 7726. According to SCImago Journal Rank (SJR), this journal is ranked 0.682. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 18. The best quartile for this journal is Q1.

The ISSN of Vaccine: X journal is 25901362. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Vaccine: X is cited by a total of 452 articles during the last 3 years (Preceding 2023).


Vaccine: X Impact IF 2023-2024


The Impact IF 2023 of Vaccine: X is 2.80, which is computed in 2024 as per its definition. Vaccine: X IF is decreased by a factor of 0.68 and approximate percentage change is -19.54% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Vaccine: X Impact IF 2024 Prediction


Impact IF 2023 of Vaccine: X is 2.80. If the same downward trend persists, Impact IF may fall in 2024 as well.


Impact IF Trend


Year wise Impact IF of Vaccine: X. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2023 2.80
2022 3.48
2021 3.69
2020 2.92
2019 0.00

Vaccine: X h-index


  Table Setting

Vaccine: X has an h-index of 18. It means 18 articles of this journal have more than 18 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Vaccine: X ISSN


The ISSN of Vaccine: X is 25901362. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Vaccine: X Rank and SCImago Journal Rank (SJR)


The overall rank of Vaccine: X is 7726. According to SCImago Journal Rank (SJR), this journal is ranked 0.682. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Vaccine: X by Year


Year SJR
2023/2024 Coming Soon
2023 0.682
2022 1.509
2021 1.129
2020 1.316
2019

Ranking of Vaccine: X by Year


Year Ranking
2023/2024 Coming Soon
2023 7726
2022 2114
2021 3363
2020 2825
2019 32689

Vaccine: X Publisher


Table Setting

Vaccine: X is published by Elsevier Ltd. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2019-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Vaccine: X is Vaccine: X. This abbreviation ('Vaccine: X') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Vaccine: X


If your research field is/are related to Veterinary (miscellaneous) (Q1); Immunology and Microbiology (miscellaneous) (Q2); Infectious Diseases (Q2); Public Health, Environmental and Occupational Health (Q2); Molecular Medicine (Q3), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Vaccine: X?

Vaccine: X latest impact IF is 2.80. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 3.69 (2021) and 0.00 (2019), respectively, in the last 5 years. Moreover, its average IS is 2.58 in the previous 5 years.


What's the SCImago Journal Rank (SJR) of the Vaccine: X?

The Vaccine: X has an SJR (SCImago Journal Rank) of 0.682, according to the latest data. It is computed in the year 2024. In the past 5 years, this journal has recorded a range of SJR, with the highest being 1.509 in 2022 and the lowest being in 2019. Furthermore, the average SJR of the Vaccine: X over the previous 5-year period stands at 2.58.


What's the latest h-index of the Vaccine: X?

The latest h-index of the Vaccine: X is 18.


Who's the publisher of the Vaccine: X?

The Vaccine: X is published by the Elsevier Ltd, with its country of publication being the United Kingdom.


What's the current ranking of the Vaccine: X?

The Vaccine: X is currently ranked 7726 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 5 years, this journal has experienced varying rankings, reaching its highest position of 2114 in 2022 and its lowest position of 32689 in 2019.


What's the abbreviation or short name for the Vaccine: X?

The standard ISO4 abbreviation for the Vaccine: X is Vaccine: X.


Is the "Vaccine: X" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Vaccine: X is classified as a journal that the Elsevier Ltd publishes.


What's the scope or major areas of the Vaccine: X?

The Vaccine: X encompasses the following areas:

  • Veterinary (miscellaneous)
  • Immunology and Microbiology (miscellaneous)
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • Molecular Medicine

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Vaccine: X?

The Vaccine: X is assigned the following International Standard Serial Numbers (ISSN): 25901362.


What's the best quartile of the Vaccine: X?

The best quartile for the Vaccine: X is Q1 (2023).


What's the coverage history of the Vaccine: X?

The Vaccine: X coverage history can be summarized as follows: 2019-2023.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Journal of Business Economics and Management journal 9513 Vilnius Gediminas Technical University 48 3.30
Zeitschrift fur Germanistische Linguistik journal 14988 Walter de Gruyter GmbH 16 0.40
Journal of Geriatric Physical Therapy journal 9578 Lippincott Williams and Wilkins Ltd. 47 1.23
Discourse journal 6196 Routledge 65 2.36
International Journal of Applied Linguistics journal 6241 Wiley-Blackwell Publishing Ltd 53 1.91
European Journal of Education journal 4662 Wiley-Blackwell Publishing Ltd 59 3.64
Journal of Sociolinguistics journal 3273 Wiley-Blackwell Publishing Ltd 64 1.85
International Conference on Architectural Support for Programming Languages and Operating Systems - ASPLOS conference and proceedings 678 Association for Computing Machinery (ACM) 106 7.58
Proceedings of the Technical Association of the Graphic Arts, TAGA conference and proceedings 30903 Technical Association of the Graphic 8 0.00
Asian Textile Journal trade journal 27997 G P S Kwatra 11 0.03

Check complete list




Year wise Impact Score (IS) of Vaccine: X

Impact Score Table

Year Impact Score (IS)
2024/2025 Coming Soon
2023 2.80
2022 3.48
2021 3.69
2020 2.92
2019 0.00



Top Journals/Conferences in Veterinary (miscellaneous)

Annual Review of Animal Biosciences
Annual Reviews Inc. | United States

GeroScience
Springer Science and Business Media Deutschland GmbH | Switzerland

Vaccine
Elsevier B.V. | Netherlands

Veterinary Quarterly
Taylor and Francis Ltd. | United Kingdom

Animal Microbiome
BioMed Central Ltd | United Kingdom

Animal Models and Experimental Medicine
John Wiley and Sons Inc. | United States

Journal of Veterinary Internal Medicine
Wiley-Blackwell | United States

Transboundary and Emerging Diseases
| United Kingdom

Current Research in Parasitology and Vector-Borne Diseases
Elsevier B.V. | Netherlands

Veterinary Research
BioMed Central Ltd | United Kingdom

See All

Top Journals/Conferences in Immunology and Microbiology (miscellaneous)

Nature Reviews Microbiology
Nature Publishing Group | United Kingdom

Cell Host and Microbe
Cell Press | United States

Clinical Microbiology Reviews
American Society for Microbiology | United States

EMBO Journal
Springer Nature | Germany

Molecular Systems Biology
Springer Nature | United Kingdom

eLife
eLife Sciences Publications | United Kingdom

PLoS Biology
Public Library of Science | United States

Microbiology and Molecular Biology Reviews
American Society for Microbiology | United States

Proceedings of the Royal Society B: Biological Sciences
The Royal Society | United Kingdom

Current Protocols
John Wiley & Sons Inc. | United States

See All

Top Journals/Conferences in Infectious Diseases

Immunity
Cell Press | United States

Nature Reviews Microbiology
Nature Publishing Group | United Kingdom

Clinical Microbiology Reviews
American Society for Microbiology | United States

Lancet Infectious Diseases, The
Lancet Publishing Group | United Kingdom

Lancet Microbe, The
Elsevier Ltd | United Kingdom

Cellular and Molecular Immunology
Nature Publishing Group | United Kingdom

Drug Resistance Updates
Churchill Livingstone | United States

Lancet HIV,The
Elsevier Ltd | United Kingdom

Clinical Infectious Diseases
Oxford University Press | United Kingdom

Microbiology and Molecular Biology Reviews
American Society for Microbiology | United States

See All

Top Journals/Conferences in Public Health, Environmental and Occupational Health

Lancet Public Health, The
Elsevier Ltd | United Kingdom

Clinical Microbiology Reviews
American Society for Microbiology | United States

Annual Review of Public Health
Annual Reviews Inc. | United States

Lancet Planetary Health, The
Elsevier B.V. | Netherlands

Implementation Science
BioMed Central Ltd | United Kingdom

Lancet Regional Health - Americas, The
Elsevier Ltd | United Kingdom

Eurosurveillance
European Centre for Disease Prevention and Control (ECDC) | Sweden

Obesity Reviews
Wiley-Blackwell Publishing Ltd | United Kingdom

Milbank Quarterly
Wiley-Blackwell Publishing Ltd | United Kingdom

Trauma, Violence, and Abuse
SAGE Publications Ltd | United Kingdom

See All

Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Molecular Cancer
BioMed Central Ltd | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Genome Medicine
BioMed Central Ltd | United Kingdom

EMBO Molecular Medicine
Springer | United Kingdom

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Experimental and Molecular Medicine
Korean Society of Med. Biochemistry and Mol. Biology | South Korea

Trends in Molecular Medicine
Elsevier Ltd | United Kingdom

See All